ctrl K

Price Alert

Krystal Biotech Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

150.42

0.09 (0.06%)

At close: Aug 15, 2025, 3:59 PM

150.27

-0.10%

After-hours: Aug 15, 2025, 05:36 PM EDT

Krystal Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	344.87M	358.33M	161.9M	341.25M
Short-Term Investments	252.65M	173.85M	217.27M	96.85M
Long-Term Investments	152.11M	61.95M	4.62M	64.37M
Other Long-Term Assets	231K	263K	324K	74K
Receivables	104.75M	42.04M	n/a	n/a
Inventory	26.51M	6.99M	n/a	n/a
Other Current Assets	13.27M	6.71M	4.61M	4.17M
Total Current Assets	742.04M	587.91M	383.78M	442.27M
Property-Plant & Equipment	161.45M	168.23M	169.73M	119.58M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	313.79M	230.45M	174.67M	184.03M
Total Assets	1.06B	818.36M	558.45M	626.29M
Account Payables	4.99M	1.85M	3.98M	8.4M
Deferred Revenue	n/a	n/a	n/a	16.21M
Short-Term Debt	n/a	n/a	1.56M	n/a
Other Current Liabilities	2.4M	16.75M	14.92M	13.41M
Total Current Liabilities	102M	33.09M	28.85M	25.74M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.42M	n/a	n/a	n/a
Total Long-Term Liabilities	7.46M	6.62M	7.37M	6.98M
Total Liabilities	109.46M	39.71M	36.22M	32.72M
Total Debt	7.26M	8.09M	8.93M	8.02M
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-180.67M	-269.83M	-280.76M	-140.78M
Comprehensive Income	-190K	638K	-728K	-163K
Shareholders Equity	946.38M	778.64M	522.23M	593.58M
Total Investments	404.77M	235.8M	221.89M	161.22M